C9orf164 Inhibitors

Compounds such as Wortmannin and LY294002 are known to inhibit PI3K, a kinase that plays a pivotal role in cell growth and survival. By inhibiting this kinase, these compounds can modulate the function of proteins that are regulated by the PI3K/Akt pathway. PD98059 and U0126, which specifically target MEK1/2 within the MAPK/ERK pathway, can alter the activity of proteins that are part of this signaling cascade, a critical route for cell proliferation and differentiation. Furthermore, inhibitors such as SB203580 and SP600125 target stress-responsive kinases like p38 MAPK and JNK, respectively. These enzymes are involved in the cellular response to stress and apoptosis, and their inhibition can affect proteins that are associated with these pathways. Compounds like Rapamycin, which inhibits mTOR, can disrupt processes like protein synthesis and autophagy, affecting proteins that are regulated by mTOR signaling.

Inhibitors targeting fundamental cellular functions include Brefeldin A, Tunicamycin, and Thapsigargin. Brefeldin A disrupts ER to Golgi transport, affecting proteins involved in vesicular trafficking. Tunicamycin blocks N-linked glycosylation, altering the stability and function of glycosylated proteins. Thapsigargin inhibits the SERCA pump, disrupting calcium homeostasis, which can affect proteins associated with calcium signaling. Cyclosporin A, by inhibiting calcineurin, can alter the function of proteins involved in T-cell activation and other signaling mechanisms, while 2-Deoxy-D-glucose, by inhibiting glycolysis, can affect proteins that are involved in metabolic regulation.